Study Evaluating DVS-233 SR to Treat Vasomotor Systems Associated With Menopause

PHASE3CompletedINTERVENTIONAL

Enrollment

568

Participants

Timeline

Start Date

September 30, 2004

Study Completion Date

July 31, 2005

Conditions

MenopauseHot FlashesSleep Disorders

Interventions

DRUG

DVS-233 SR

All Listed Sponsors

lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00256685 - Study Evaluating DVS-233 SR to Treat Vasomotor Systems Associated With Menopause | Biotech Hunter | Biotech Hunter